Handel nachbörslich: .72 0.004 +0.56%

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Why Is Cancer Focused Penny Stock Vincerx Pharma Trading Higher Today? - MSN

Vincerx Pharma (NASDAQ:VINC) Trading Down 2.1% - Defense World

A better buy-in window may exist right now for Vincerx Pharma Inc (VINC) - SETE News

Investing in Vincerx Pharma Inc (VINC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely - Simply Wall St

Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky - Yahoo Finance

Vanguard Group Inc. Has $3.38 Million Position in Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World

Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval - TipRanks

VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024 - MSN

Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewswire

Vincerx Pharma Reports Second Quarter 2024 Financial Results - StockTitan

Vincerx Pharma Reports Second Quarter 2024 Financial Results - Yahoo Finance

Acadian Asset Management LLC Sells 36,571 Shares of Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Decreases By 31.7% - Defense World

How should investors view Vincerx Pharma Inc (VINC)? – US Post News - US Post News

Vincerx Pharma Inc (VINC) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Down 29.3% in June - Defense World

Vincerx Pharma Inc Inc. (VINC) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade - MSN

Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Vincerx Pharma (NASDAQ:VINC) Trading Down 7.1% - Defense World

Balance Sheet Insights: Vincerx Pharma Inc (VINC)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Investing News Network

Vincerx Pharma to Participate in the Jefferies Virtual Healthcare Conference - The Globe and Mail

Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World

Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual ... - The Globe and Mail

Vincerx Pharma Reports First Quarter 2021 Financial Results and Provides a Corporate Update - The Globe and Mail

Vincerx Pharma Announces Completion of Public Warrant Redemption - The Globe and Mail

Market Recap Check: Vincerx Pharma Inc (VINC)'s Negative Finish at 0.68, Up/Down -2.81 – DWinneX - The Dwinnex

Is Vincerx Pharma Inc (VINC) a threat to investors? – US Post News - US Post News

Vincerx Pharma (VINC) Price Target Increased by 10.53% to 7.14 - MSN

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday? - MSN

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Investing.com India

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - The Bakersfield Californian

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Market Update: Vincerx Pharma Inc (VINC) Sees Positive Movement, Closing at 0.84 – DWinneX - The Dwinnex

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewswire

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewswire Inc.

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - GlobeNewswire Inc.

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - Yahoo Finance

Vincerx Blames Stock Plunge On Overheated ADC Expectations - Scrip

Crude Oil Down Over 1%; Cognyte Software Shares Plummet - Benzinga

Vincerx (VINC) Tumbles on Results From Cancer Therapy Study - Zacks Investment Research

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga

Dow Dips 150 Points; Laser Photonics Shares Spike Higher - Benzinga

Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings - Benzinga

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Benzinga

Vincerx (VINC) Tumbles on Results From Cancer Therapy Study - Yahoo Finance

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewswire Inc.

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Yahoo Finance

Vincerx Pharma (VINC) Earnings Date and Reports 2024 - MarketBeat

VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023 - InvestorPlace

Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Yahoo Finance

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update - Yahoo Finance

Vincerx Pharma Inc (VINC) Stock Gains 1.83% This Week; Should You Buy? - InvestorsObserver

VINC Stock Price and Chart — NASDAQ:VINC — TradingView - TradingView

Should You Add Vincerx Pharma Inc (VINC) Stock to Your Portfolio Thursday? - InvestorsObserver

Should You Buy Vincerx Pharma Inc (VINC) Stock After it Is Down 0.60% in a Week? - InvestorsObserver

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider

Will Vincerx Pharma Inc (VINC) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Is it Time to Dump Vincerx Pharma Inc (VINC) Stock After it Is Up 85.79% in a Week? - InvestorsObserver

Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week - Yahoo Finance

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving PremarketAinos (NASDAQ:AI - Benzinga

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma - Yahoo Finance

15 Best Falling Stocks To Buy Now - Insider Monkey

Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023 - GlobeNewswire

Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Yahoo Finance

The ‘elegant science’ in achieving the promise of ADCs - pharmaphorum

Vincerx Pharma To Present Three Posters at ASH 2023 in December - StockTitan

FDA approves Vincerx’s IND application for trial of VIP943 - Clinical Trials Arena

Ähnlich wie VINC